GILD

Nasdaq

GILEAD SCIENCES, INC.

Latest disclosureOctober 2, 2026

Insider score Why 0?: 0/ 100
Qualifying buys · 30d: $0

0 purchases · 45 sales

Price by TradingView

Insider transactions 115

Limited filing history

Filters

Last 30 daysNo qualifying insider buying. Sales: $3.09M by 3 insiders.

Showing the first 6 of 20 trades on this page.

Sale disclosed

Daniel Patrick O.'Day

Chairman & CEO

Common Stock

Reported value: $1.77M
Reported price: $147.719 / share

Sale disclosed

Daniel Patrick O.'Day

Chairman & CEO

Common Stock

Reported value: $445.88K
Reported price: $148.6265 / share

Sale disclosed

Andrew D. Dickinson

Chief Financial Officer

Common Stock

Reported value: $435.87K
Reported price: $145.29 / share

Sale disclosed

Johanna Mercier

Chief Comm & Corp Aff Officer

Common Stock

Reported value: $229.91K
Reported price: $143.6917 / share

Sale disclosed

Johanna Mercier

Chief Comm & Corp Aff Officer

Common Stock

Reported value: $115.57K
Reported price: $144.4569 / share

Sale disclosed

Johanna Mercier

Chief Comm & Corp Aff Officer

Common Stock

Reported value: $87.17K
Reported price: $145.29 / share

Sale disclosed

Daniel Patrick O.'Day

Chairman & CEO

Common Stock

Reported value: $236.01K
Reported price: $147.5087 / share

Sale disclosed

Daniel Patrick O.'Day

Chairman & CEO

Common Stock

Reported value: $1.19M
Reported price: $148.3636 / share

Sale disclosed

Daniel Patrick O.'Day

Chairman & CEO

Common Stock

Reported value: $807.86K
Reported price: $149.3817 / share

Sale disclosed

Anthony Welters

Director

Common Stock

Reported value: $462.43K
Reported price: $148.3106 / share

Sale disclosed

Anthony Welters

Director

Common Stock

Reported value: $684.59K
Reported price: $148.824 / share

Sale disclosed

Anthony Welters

Director

Common Stock

Reported value: $504.3K
Reported price: $148.2353 / share

Sale disclosed

Anthony Welters

Director

Common Stock

Reported value: $1.02M
Reported price: $148.8227 / share

Sale disclosed

Jeffrey Bluestone

Director

Common Stock

Reported value: $167.47K
Reported price: $143.7543 / share

Sale disclosed

Jeffrey Bluestone

Director

Common Stock

Reported value: $263.18K
Reported price: $144.9248 / share

Sale disclosed

Jeffrey Bluestone

Director

Common Stock

Reported value: $241.62K
Reported price: $145.7286 / share

Sale disclosed

Jeffrey Bluestone

Director

Common Stock

Reported value: $3.81K
Reported price: $146.36 / share

Sale disclosed

Jeffrey Bluestone

Director

Common Stock

Reported value: $49K
Reported price: $146.26 / share

Sale disclosed

Andrew D. Dickinson

Chief Financial Officer

Common Stock

Reported value: $415.08K
Reported price: $138.36 / share

Sale disclosed

Johanna Mercier

Chief Comm & Corp Aff Officer

Common Stock

Reported value: $2.27M
Reported price: $137.365 / share

Reporting insider	Security / transaction	Amount / price	Value	Traded / disclosed	Source
Chairman & CEO	Common StockSale10b5-12 trades	15,000avg $147.90 / share	$2.22M	Oct 1Filed Oct 2 · 1d later	2 filings 12,000 @ $147.72 · $1.77MSEC filing 3,000 @ $148.63 · $445.88KSEC filing
Chief Financial Officer	Common StockSale10b5-1	3,000$145.29 / share	$435.87K	Sep 15Filed Sep 16 · 1d later	SEC filing
Chief Comm & Corp Aff Officer	Common StockSale10b5-13 trades	3,000avg $144.22 / share	$432.65K	Sep 15Filed Sep 16 · 1d later	3 filings 1,600 @ $143.69 · $229.91KSEC filing 800 @ $144.46 · $115.57KSEC filing 600 @ $145.29 · $87.17KSEC filing
Chairman & CEO	Common StockSale10b5-13 trades	15,000avg $148.64 / share	$2.23M	Sep 1Filed Sep 2 · 1d later	3 filings 1,600 @ $147.51 · $236.01KSEC filing 7,992 @ $148.36 · $1.19MSEC filing 5,408 @ $149.38 · $807.86KSEC filing
Director	Common StockSale10b5-14 trades	18,000avg $148.62 / share	$2.68M	Aug 26Filed Aug 27 · 1d later	4 filings 3,118 @ $148.31 · $462.43KSEC filing 4,600 @ $148.82 · $684.59KSEC filing 3,402 @ $148.24 · $504.3KSEC filing 6,880 @ $148.82 · $1.02MSEC filing
Director	Common StockSale10b5-15 trades	5,000avg $145.02 / share	$725.08K	Aug 20Filed Aug 21 · 1d later	5 filings 1,165 @ $143.75 · $167.47KSEC filing 1,816 @ $144.92 · $263.18KSEC filing 1,658 @ $145.73 · $241.62KSEC filing 26 @ $146.36 · $3.81KSEC filing 335 @ $146.26 · $49KSEC filing
Chief Financial Officer	Common StockSale10b5-1	3,000$138.36 / share	$415.08K	Aug 17Filed Aug 18 · 1d later	SEC filing
Chief Comm & Corp Aff Officer	Common StockSale10b5-1	16,530$137.37 / share	$2.27M	Aug 17Filed Aug 18 · 1d later	SEC filing

Showing the latest 20 of 45 trades. Show all 45 trades

Congress transactions 9

All Congress filings

Purchase disclosedAmended report

Gilead Sciences Inc · Options

The filing reports a purchase for a joint account.

Thomas H TubervilleReporting Senate member

Options or exercise activity is reported; this is not automatically an ordinary share purchase.

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: May 10, 2024

Purchase disclosedAmended report

Gilead Sciences Inc · Options

The filing reports a purchase for a joint account.

Thomas H TubervilleReporting Senate member

Options or exercise activity is reported; this is not automatically an ordinary share purchase.

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: May 10, 2024

Purchase disclosedAmended report

Gilead Sciences Inc · Options

The filing reports a purchase for a joint account.

Thomas H TubervilleReporting Senate member

Options or exercise activity is reported; this is not automatically an ordinary share purchase.

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: May 10, 2024

Full sale disclosedAmended report

Gilead Sciences, Inc. - Common Stock · Stock

The filing reports a full sale for a joint account.

Thomas H TubervilleReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: May 8, 2024

Purchase disclosed

Gilead Sciences, Inc. - Common Stock · Stock

The filing reports a purchase for the member.

AAAlan ArmstrongReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: March 27, 2026

Purchase disclosed

Gilead Sciences, Inc. - Common Stock (GILD) · Stock

The filing reports a purchase for the member.

Jared MoskowitzReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: May 6, 2026

Purchase disclosed

Gilead Sciences, Inc. - Common Stock (GILD) · Stock

The filing reports a purchase for a dependent.

Jared MoskowitzReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: May 6, 2026

Purchase disclosed

Gilead Sciences, Inc. - Common Stock (GILD) · Stock

The filing reports a purchase for a joint account.

Josh GottheimerReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: January 27, 2026

Sale disclosed

Gilead Sciences, Inc. - Common Stock (GILD) · Stock

The filing reports a sale for a spouse.

Valerie HoyleReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: September 23, 2025

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0000882095
Latest public acceptance: Oct 2, 2026, 08:40 PM UTC
Score calculated: Oct 7, 2026, 12:05 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.

Reporting insider

Security / transaction

Amount / price

Value

Traded / disclosed

Source

Chairman & CEO

Common StockSale10b5-12 trades

15,000avg $147.90 / share

$2.22M

Oct 1Filed Oct 2 · 1d later

2 filings

12,000 @ $147.72 · $1.77MSEC filing
3,000 @ $148.63 · $445.88KSEC filing

Chief Financial Officer

Common StockSale10b5-1

3,000$145.29 / share

$435.87K

Sep 15Filed Sep 16 · 1d later

SEC filing

Chief Comm & Corp Aff Officer

Common StockSale10b5-13 trades

3,000avg $144.22 / share

$432.65K

Sep 15Filed Sep 16 · 1d later

3 filings

1,600 @ $143.69 · $229.91KSEC filing
800 @ $144.46 · $115.57KSEC filing
600 @ $145.29 · $87.17KSEC filing

Chairman & CEO

Common StockSale10b5-13 trades

15,000avg $148.64 / share

$2.23M

Sep 1Filed Sep 2 · 1d later

3 filings

1,600 @ $147.51 · $236.01KSEC filing
7,992 @ $148.36 · $1.19MSEC filing
5,408 @ $149.38 · $807.86KSEC filing

Director

Common StockSale10b5-14 trades

18,000avg $148.62 / share

$2.68M

Aug 26Filed Aug 27 · 1d later

4 filings

3,118 @ $148.31 · $462.43KSEC filing
4,600 @ $148.82 · $684.59KSEC filing
3,402 @ $148.24 · $504.3KSEC filing
6,880 @ $148.82 · $1.02MSEC filing

Director

Common StockSale10b5-15 trades

5,000avg $145.02 / share

$725.08K

Aug 20Filed Aug 21 · 1d later

5 filings

1,165 @ $143.75 · $167.47KSEC filing
1,816 @ $144.92 · $263.18KSEC filing
1,658 @ $145.73 · $241.62KSEC filing
26 @ $146.36 · $3.81KSEC filing
335 @ $146.26 · $49KSEC filing

Chief Financial Officer

Common StockSale10b5-1

3,000$138.36 / share

$415.08K

Aug 17Filed Aug 18 · 1d later

SEC filing

Chief Comm & Corp Aff Officer

Common StockSale10b5-1

16,530$137.37 / share

$2.27M

Aug 17Filed Aug 18 · 1d later

SEC filing

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0000882095
Latest public acceptance: Oct 2, 2026, 08:40 PM UTC
Score calculated: Oct 7, 2026, 12:05 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.